δ-opioid receptor

OPRD1
Available structures
PDB	Ortholog search: PDBe RCSB
List of PDB id codes
	4N6H, 4RWA, 4RWD
Identifiers
Aliases	OPRD1, OPRD, Δ-opioid receptor, opioid receptor delta 1, DOP, DOR1, DOR
External IDs	OMIM: 165195; MGI: 97438; HomoloGene: 20252; GeneCards: OPRD1; OMA:OPRD1 - orthologs
Gene location (Human)
Chr.	Chromosome 1 (human)
End	28,871,267 bp
Gene location (Mouse)
Chr.	Chromosome 4 (mouse)
End	131,871,797 bp
RNA expression pattern
	Top expressed in
	endothelial cell; ; islet of Langerhans; ; primary visual cortex; ; prefrontal cortex; ; right frontal lobe; ; middle temporal gyrus; ; superior frontal gyrus; ; Brodmann area 23; ; dorsolateral prefrontal cortex; ; Brodmann area 9;
	Top expressed in
	trophoblast giant cell; ; pituitary stalk; ; primary oocyte; ; secondary oocyte; ; zygote; ; superior frontal gyrus; ; outer nuclear layer; ; primary visual cortex; ; primary trophoblast giant cell; ; dentate gyrus of hippocampal formation granule cell;
	More reference expression data
	More reference expression data
Gene ontology
Molecular function	G protein-coupled enkephalin receptor activity; G protein-coupled receptor activity; neuropeptide binding; signal transducer activity; G protein-coupled opioid receptor activity; protein binding; receptor serine/threonine kinase binding; peptide binding;
Cellular component	cytoplasm; axon terminus; integral component of membrane; vesicle; postsynaptic membrane; membrane; intrinsic component of plasma membrane; plasma membrane; integral component of plasma membrane; dendrite membrane; membrane raft; neuron projection; integral component of synaptic vesicle membrane; spine apparatus; neuronal dense core vesicle; integral component of presynaptic membrane; integral component of postsynaptic density membrane;
Biological process	regulation of calcium ion transport; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; regulation of sensory perception of pain; eating behavior; adult locomotory behavior; negative regulation of protein oligomerization; cellular response to growth factor stimulus; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; cellular response to toxic substance; negative regulation of gene expression; positive regulation of peptidyl-serine phosphorylation; regulation of mitochondrial membrane potential; phospholipase C-activating G protein-coupled receptor signaling pathway; positive regulation of CREB transcription factor activity; G protein-coupled opioid receptor signaling pathway; immune response; neuropeptide signaling pathway; cellular response to hypoxia; signal transduction; chemical synaptic transmission; sensory perception of pain; G protein-coupled receptor signaling pathway; cytokine-mediated signaling pathway;
	Sources:Amigo / QuickGO
Orthologs
	4985
	18386
	ENSG00000116329
	ENSMUSG00000050511
	P41143
	P32300
	NM_000911
	NM_013622
	NP_000902
	NP_038650
	Wikidata
View/Edit Human	View/Edit Mouse

The δ-opioid receptor, also known as delta opioid receptor or simply delta receptor, abbreviated DOR or DOP, is an inhibitory 7-transmembrane G-protein coupled receptor coupled to the G protein G_i/G₀ and has enkephalins as its endogenous ligands.^[5] The regions of the brain where the δ-opioid receptor is largely expressed vary from species model to species model. In humans, the δ-opioid receptor is most heavily expressed in the basal ganglia and neocortical regions of the brain.^[6]

^ ^a ^b ^c GRCh38: Ensembl release 89: ENSG00000116329 – Ensembl, May 2017
^ ^a ^b ^c GRCm38: Ensembl release 89: ENSMUSG00000050511 – Ensembl, May 2017
^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^ Quock RM, Burkey TH, Varga E, Hosohata Y, Hosohata K, Cowell SM, et al. (September 1999). "The delta-opioid receptor: molecular pharmacology, signal transduction, and the determination of drug efficacy". Pharmacological Reviews. 51 (3): 503–532. PMID 10471416.
^ Peppin JF, Raffa RB (April 2015). "Delta opioid agonists: a concise update on potential therapeutic applications". Journal of Clinical Pharmacy and Therapeutics. 40 (2): 155–166. doi:10.1111/jcpt.12244. PMID 25726896. S2CID 25483387.

[refGRCh38Ensembl-1] GRCh38: Ensembl release 89: ENSG00000116329 – Ensembl, May 2017

[refGRCm38Ensembl-2] GRCm38: Ensembl release 89: ENSMUSG00000050511 – Ensembl, May 2017

[3] "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.

[4] "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.

[pmid10471416-5] Quock RM, Burkey TH, Varga E, Hosohata Y, Hosohata K, Cowell SM, et al. (September 1999). "The delta-opioid receptor: molecular pharmacology, signal transduction, and the determination of drug efficacy". Pharmacological Reviews. 51 (3): 503–532. PMID 10471416.

[6] Peppin JF, Raffa RB (April 2015). "Delta opioid agonists: a concise update on potential therapeutic applications". Journal of Clinical Pharmacy and Therapeutics. 40 (2): 155–166. doi:10.1111/jcpt.12244. PMID 25726896. S2CID 25483387.

[1]

[2]

[3]

[4]

[5]

[6]